Infertility has become a globally important issue in reproductive health. Approximately 10%-15% of reproductive-aged couples worldwide are afflicted by infertility, which is attributable to men in approximately 50% of cases (Sabanegh, 2011). According to World Health Organization (WHO) guidelines, male infertility is defined as the inability to conceive after at least 12 months of regular, unprotected sexual intercourse (Zegers-Hochschild et al., 2009).Asthenozoospermia is detected in 40% of infertile men, which is mainly characterised by low sperm motility (Jungwirth et al., 2012).Asthenozoospermia is caused by many factors, such as genetic disorders, infection, abnormal semen liquefaction, immune factors, endocrine factors, Kartagener's syndrome, chromosomal abnormalities, varicocele, micronutrient deficiency and poor lifestyle habits (Jungwirth et al., 2017). As the main feature of asthenospermia, low sperm motility is associated with the following conditions: abnormal sperm motility apparatus, impaired sperm energy metabolism and blocked cell signaling. However, the specific molecular mechanism underlying asthenozoospermia has not been thoroughly elucidated. Basic research data suggest that multiple gene expression abnormalities in different signaling pathways may be associated with the development of asthenozoospermia.Although sperm are highly specialised cells, they contain a certain amount of RNA, primarily mRNA and miRNA (DeJong, 2006).Sperm RNA plays very important roles in sperm motility, capacitation, fertilisation and embryo development (Boerke et al., 2007;